Med-X, Inc. Receives Patent on Nature-Cide Insecticidal Soil LOS ANGELES, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Med-X, Inc. (Med-X) announced that in October 2021 the Company received Patent No. 11,147,266 B2 for its Nature-Cide Insecticidal Soil formulation....

Med-X, Inc. Relaunches its Regulation A+ Crowdfunding Offering in Preparation for a Public Market Listing to Access its $100MM Capital Commitment LOS ANGELES, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Med-X, Inc. (Med-X) today announced the re-launch of its Regulation A+ Crowdfunding campaign at www.medxinvestor.com. Med-X has recently secured a...